$IBIO we are next and we are ready to manufacture! Stock is going up and it’s not because of Stocktwits! Next stop$7-$9 on no news The world’s largest vaccine-maker GSK has put its vaccine booster technology into a potential new COVID-19 shot, to be developed with a Canadian biopharmaceutical company backed by tobacco company Philip Morris. Rather than developing its own vaccine in the global race to combat the pandemic, GSK has instead focused on contributing its adjuvant technology to at least seven other global companies, including Sanofi and China’s Clover.
  • 9
9 Likes